ProtaGene
Signal active
Organization
Contact Information
Overview
ProtaGene is an analytic service provider across the biopharmaceutical, cell, and gene therapy development spaces. They provide complete protein and gene analytic capabilities and packages for biologic therapeutics as well as cell and gene therapy platforms. They offer product testing and analytical packages for product lifecycle management.
About
Industries
Biotechnology, Biopharma, Therapeutics
Founded
1997
Employees
51-100
Headquarters locations
Europe
Social
N/A
Profile Resume
ProtaGene headquartered in Europe, operates in the Biotechnology, Biopharma, Therapeutics sector. With a team of 51-100 employees, ProtaGene is actively contributing to advancements in Biotechnology. Their latest funding round, Private Equity Round - ProtaGene, raised $Unknown amount. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
1
Investors
1
Lead Investors
0
Total Funding Amount
$0
Details
1
ProtaGene has raised a total of $0 in funding over 1 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2023 | Private Equity |
Investors
ProtaGene is funded by 2 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| ProtaGene | - | FUNDING ROUND - ProtaGene | undefined |
| Ampersand Capital Partners | - | FUNDING ROUND - Ampersand Capital Partners | undefined |
Recent Activity
There is no recent news or activity for this profile.